Evaluation of Large Panels of Bispecific Antibodies Using Surface Plasmon Resonance

Antibody Society Conference, Sendai, Japan
December 9, 2024

Traditional bispecific antibody (BsAb) development often faces setbacks due to early rejection of promising candidates and wasted efforts on suboptimal fragments. Embrace the future of BsAb development with our innovative end-to-end software solution designed for high-throughput in-format screening. Utilizing Surface Plasmon Resonance (SPR) and Bio-Layer Interferometry (BLI), our software streamlines the process by tracking clones, supporting their construction, and automatically calculating kinetic parameters from raw data. This advanced workflow not only scales with combinatorial complexity but also significantly reduces development times, ensuring the selection of superior BsAb lead candidates. Transform your BsAb development process with our cutting-edge technology.